1. Companion Diagnostics Market: Global Industry Analysis and
Forecast to 2020
Persistence Market Research
Companion Diagnostics Market: Global
Industry Analysis and Forecast to 2020
Persistence Market Research 1

2. Companion Diagnostics Market: Global Industry Analysis and
Forecast to 2020
Persistence Market Research Released New Market Report on “Companion Diagnostics
Market: Global Industry Analysis and Forecast to 2020”.
Companion diagnostics refer to the test or measurement which provides essential information about the
patient’s genetic and genomic characteristics to the physicians for making treatment decision. This
information is important for the safe and effective use of corresponding drugs and therapies in the
treatment. Rise in awareness about personalized medicines, technological advancement and government
initiatives are some of the major factors which are driving the companion diagnostics market. Companion
diagnostics helps to improve clinical outcome and cost saving. Companion diagnostics are used in drug
discovery and development in a cost effective manner. In addition, companion diagnostics also used to
manage side effects from the drug and therapies. On the basis of technology, companion diagnostics
market can be segmented into polymerase chain reaction (PCR), in-situ hybridization (ISH),
immunohistochemistry (IHC) and others. On the basis of application, companion diagnostics market can
be segmented into breast cancer, gastric cancer, lung cancer, colorectal cancer, melanoma and others.
On the basis of end user, companion diagnostics market can be segmented into pharmaceutical
companies, reference lab and others. Companion diagnostics methodology includes genetic tests
platforms, enzyme-linked immunosorbent assays, immunohistochemistry, proteomic assays and others.
Companion diagnostics reduce costs related to hospitalization due to unnecessary treatment.
Buy Full Report: http://www.persistencemarketresearch.com/market-research/companion-
diagnostics-market.asp
North America, followed by Europe, has the largest market for companion diagnostics due to FDA
initiatives, increasing focus on personalized medicine, technological advancement and developed
healthcare infrastructure in this region. Asia is expected to experience high growth rate in the companion
diagnostics market in next few years due to rise in incidence of cancer cases, government initiatives,
increasing disposable income, developing healthcare infrastructure and rise in need for better oncology
treatment in the region.
Government initiatives, growing need for targeted cancer treatment, increasing disposable income,
technological advancement, development of personalized medicines and its adoption, rise in cost of drug
discovery and increasing adoption of companion diagnostics by reference laboratories and
pharmaceutical companies are expected to drive the market for companion diagnostics. In addition, rise in
incidence of life threatening diseases, growing awareness about personalized healthcare and increasing
demand for better healthcare facilities are expected to drive the market for companion diagnostics.
However, reimbursement issues, non-validated laboratory developed tests, regulatory restrictions, huge
Persistence Market Research 2

3. Companion Diagnostics Market: Global Industry Analysis and
Forecast to 2020
time consuming approval process and high cost for procedure are some of the major factors restraining
the growth for global companion diagnostics market.
Growing demographics and economies in the developing countries such as India and China is expected
to lead the growth in companion diagnostics market in Asia. In addition, broader application area for
companion diagnostics, growing bioinformatics field, rise in awareness about the companion diagnostics
and forthcoming next generation sequencing based companion diagnostics are expected to offer new
opportunities for global companion diagnostics market. Increasing number of mergers and acquisitions,
new product launches and rise in number of collaborations and partnerships are some of the latest trends
that have been observed in global companion diagnostics market. Some of the major companies
operating in the global companion diagnostics market are Abbott Laboratories, Roche Holdings AG, GE
Healthcare, Quagen N.V., Genomic Health, Inc. and Agilent Technologies, Inc. In addition, some other
companies operating in global companion diagnostics market are Thermo Fisher Scientific Inc., Myriad
Genetics Inc., Biomérieux, Danaher Corporation and Biogenex Laboratories.
Request Full TOC: http://www.persistencemarketresearch.com/toc/3592
Key points covered in the report:-
1. Report segments the market on the basis of types, application, products, technology, etc
(as applicable)
2. The report covers geographic segmentation
 North America
 Europe
 Asia
 RoW
3. The report provides the market size and forecast for the different segments and
geographies for the period of 2010 to 2020
4. The report provides company profiles of some of the leading companies operating in the
market
5. The report also provides porters five forces analysis of the market.
Browse the full “All Upcoming Persistence Market's ” report at
http://www.persistencemarketresearch.com/forthcoming-reports.asp
About Us:
Persistence Market Research is a global market research firm specializing- syndicated
research, custom research, and consulting services
Persistence Market Research 3

4. Companion Diagnostics Market: Global Industry Analysis and
Forecast to 2020
At Persistence Market Research (PMR), we are in the business of accelerating your business.
As a full-service market research firm, we stand committed to bringing more accuracy and
speed to your business decisions. From ready-to-purchase market research reports to
customized global research solutions, our engagement models are highly flexible without
compromising on our deep-seated research values. Briefly stated, our mission is to give you
access to forecasts and trends analyses that put you on the path to profitability.
PMR’s Services Go Beyond Gleaning Data:
Most enterprises believe that IT and databases are enough to make an accurate decision. While
we do not dispute that, consider this: How long does it take to make an accurate and strategic
million-dollar decision? We strive to deliver both even with demanding deadlines.
Facilitating Rapid and Informed Business Decisions
PMR was founded with one goal in mind: to offer enterprises a tangible business advantage by
carefully balancing traditional and modern-day research methodologies.
Contact Us:
Addie Thomes
305 Broadway,
7th Floor,
New York City, NY 10007,
United States.
Phone: +1-646-568-7751
USA/Canada Toll Free Number.
1-800-961-0353
E-mail: Sales@persistencemarketresearch.com
Web : http://www.persistencemarketresearch.com/
Persistence Market Research 4